- €8.60bn
- €8.49bn
- €4.07bn
Brief: Biomerieux FY Net Profit At EUR 432 Mln
Earnings Poll: Biomerieux full-year results due on March 7
Brief: Biomerieux Gets U.S. FDA Clearance For New Version Of BIOFIRE® FILMARRAY® Gastrointestinal (GI) Panel Mid
Advisory: Alerts on Biomerieux' acquisition of Spinchip repeat old news and are withdrawn
Europe Research Roundup: Ferrari N.V., LVMH, Vestas
Europe Research Roundup: Auto Trader, Barry Callebaut, Firstgroup
France's BioMérieux jumps on acquisition of Norwegian SpinChip
Brief: Biomerieux To Acquire SpinChip
Europe Research Roundup: Adidas, L'Oreal, Next
RBC sees growth in IVD market, favours bioMérieux over Diasorin
Europe Research Roundup: Arkema SA, Flatexdegiro AG, Mediobanca
Biomerieux rises on Q3 sales growth above expectations
Brief: Biomerieux Q3 2024 +11% Organic Sales Growth At €969M
Europe Research Roundup: Ashmore, Biomerieux, Diasorin
Brief: Biomerieux Receives CE-Marking For Vidas® Vitamin B12 Total
Europe Research Roundup: Barclays, Ferrari, Volkswagen
Sales beat, outlook hike lift Biomerieux shares
Brief: Biomerieux FY Sales Expected To Grow Organically By 8% to 10%
Top of the Street: Admiral Group, United Utilities, Biomerieux